APA (7th ed.) Citation

Li, N., Wang, B., Li, J., Shao, Y., Li, M., Li, J., . . . Wang, S. (2022). Perioperative circulating tumor DNA as a potential prognostic marker for operable stage I to IIIA non–small cell lung cancer. Cancer, 128(4), 708-718. https://doi.org/10.1002/cncr.33985

Chicago Style (17th ed.) Citation

Li, Ning, et al. "Perioperative Circulating Tumor DNA as a Potential Prognostic Marker for Operable Stage I to IIIA Non–small Cell Lung Cancer." Cancer 128, no. 4 (2022): 708-718. https://doi.org/10.1002/cncr.33985.

MLA (9th ed.) Citation

Li, Ning, et al. "Perioperative Circulating Tumor DNA as a Potential Prognostic Marker for Operable Stage I to IIIA Non–small Cell Lung Cancer." Cancer, vol. 128, no. 4, 2022, pp. 708-718, https://doi.org/10.1002/cncr.33985.